Zaloguj Zarejestruj się zadarmo

Acorda Therapeutics Inc organizacji Forward P/E

Jaka jest wartość Forward P/E organizacji Acorda Therapeutics Inc?

Wartość Forward P/E organizacji Acorda Therapeutics Inc to -18.33

Jaka jest definicja Forward P/E?



Wskaźnik ceny do zysku to stosunek ceny akcji spółki do szacunkowego zysku spółki na akcję za następne dwanaście miesięcy.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Forward P/E firm w Health Care sektor na NASDAQ w porównaniu do Acorda Therapeutics Inc

Czym się zajmuję organizacja Acorda Therapeutics Inc?

acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate

Firmy z forward p/e podobne do Acorda Therapeutics Inc